Related by context. All words. (Click for frequent words.) 79 transaminases 78 aminotransferases 74 AST ALT 73 serum ALT 73 serum transaminases 72 hepatic enzyme 72 hepatic enzymes 72 serum aminotransferase levels 71 hepatic transaminase levels 71 aspartate aminotransferase AST 70 serum phosphate 70 aminotransferase levels 70 alanine aminotransferase 70 myopathy rhabdomyolysis 69 serum aminotransferases ALT 69 Known hypersensitivity 69 elevated ALT 69 hypophosphatemia 69 extrapyramidal symptoms 69 haematologic 68 transaminase 68 Erythropoietic therapies may 68 aminotransferase ALT 68 serum leptin 68 ALT flares 68 receiving VELCADE 68 bilirubin liver 68 hypercalcemia 68 tumor lysis syndrome 68 transaminase elevations 68 SGPT 67 Hepatotoxicity 67 hematologic parameters 67 serum urate 67 headache abdominal pain 67 aspartate aminotransferase 67 severe hypersensitivity reactions 67 oral antidiabetic medication 67 leucopenia 67 EDARBI 67 nonhematologic adverse reactions 67 alanine aminotransferase ALT 67 transaminase levels 66 receiving XGEVA 66 neutropenia thrombocytopenia 66 intravascular hemolysis 66 SCr 66 nasopharyngitis headache 66 creatine kinase MB 66 creatine kinase CK 66 elevated creatinine 66 ALB # 66 serum IGF 66 pancytopenia 66 cytopenias 66 headache nasopharyngitis 66 receiving APTIVUS r 66 lactate dehydrogenase LDH 66 colorectal adenoma 66 β blockers 66 intact parathyroid hormone 66 DLTs 66 relapsed MM 66 serum phosphorous 66 HER2 expression 66 renal toxicity 66 creatine kinase 66 serum calcium levels 66 plasma lipoprotein 66 moderate renal impairment 66 CK MB 65 macroalbuminuria 65 anaphylactic reactions bronchospasm 65 Serious adverse reactions 65 EXJADE 65 aminotransferase 65 serum urate levels 65 Infusion Reactions Severe 65 paraprotein 65 plasma triglycerides 65 prolonged QT interval 65 urate lowering 65 glycosylated hemoglobin HbA1c 65 anemia neutropenia 65 nephrotoxicity 65 renal impairment 65 serum homocysteine 65 inflammatory biomarkers 65 serum uric acid 65 hypomagnesemia 65 REYATAZ r arm 65 hematologic toxicity 65 glomerular filtration 65 deep venous thromboses 65 Febrile neutropenia 65 eosinophilia 65 plasma uric acid 65 thrombotic events 65 TNF blocker therapy 65 tryptase 65 HMG CoA reductase inhibitors 65 Thrombotic thromboembolic complications 65 hypercalcaemia 65 BENICAR HCT 64 thrombophlebitis 64 Tumor shrinkage 64 Adverse effects 64 pancreatic prostate 64 gastrointestinal toxicities 64 fluvastatin 64 QTc prolongation 64 sitaxsentan 64 Ribavirin causes 64 lactate dehydrogenase 64 morphometric vertebral fractures 64 serum triglycerides 64 Primary endpoints 64 prospectively stratified 64 agitation irritability 64 intravenous bisphosphonates 64 demonstrated antitumor activity 64 liver enzymes ALT 64 posaconazole 64 intracranial hemorrhage ICH 64 serum retinol 64 PASI scores 64 serum cortisol 64 lymphomas leukemias 64 Insulin sensitivity 64 thromboembolic events 64 pretransplant 64 paricalcitol 64 urinary calcium 64 ALT AST 64 HIV HCV coinfected 64 Hematologic 64 pheochromocytoma 64 APTIVUS r 64 vasogenic edema 64 serum HBV DNA 64 elevated liver enzymes 64 serum creatinine levels 64 hematological parameters 64 myelosuppression 64 specific antigen PSA 64 ruboxistaurin 64 headache nausea diarrhea 63 plasma lipids 63 Reversible Posterior Leukoencephalopathy Syndrome 63 Fasting blood glucose 63 mild renal insufficiency 63 urinary N telopeptide 63 capillary leakage 63 plasma pharmacokinetics 63 peginterferon alfa 63 inducible nitric oxide synthase 63 VIIBRYD 63 nonfasting triglycerides 63 hyperphenylalaninemia HPA due 63 hyperhomocysteinemia 63 hypercalciuria 63 Hypotension 63 urinary oxalate 63 K ras mutations 63 echocardiographic parameters 63 cobiprostone 63 postoperative AF 63 danazol 63 SGOT 63 Myelosuppression 63 pathologic fractures 63 splenectomized patients 63 hepatotoxicity 63 desvenlafaxine succinate 63 somnolence dizziness 63 hemodilution 63 syncope fainting 63 homozygous familial hypercholesterolemia 63 pruritus rash 63 normal ULN 63 lipoprotein Lp 63 Lp PLA 2 63 concomitant medications 63 Mg Uk 63 unstable angina pectoris 63 nicardipine 63 neutropenia dehydration dyspnea 63 tolvaptan 63 TEAEs 63 Postoperative complications 63 serum potassium 63 triglyceride TG 63 hsCRP levels 63 thrombocytopenia neutropenia 63 unresectable HCC 63 vitamin B# folic acid 63 AML MDS 63 pharmacokinetic interactions 63 lymphocytosis 63 eculizumab therapy 63 fasting glucose levels 63 dose proportionality 63 angioneurotic edema 63 Plasma concentrations 63 serum BDNF 63 reactogenicity 63 pulmonary exacerbations 63 hematological toxicity 63 achieved ACR# 63 lens opacities 63 PLX STROKE targeting 63 coadministration 63 Exclusion criteria 63 elevated LDH 63 hormone receptor negative 63 serum lipid levels 63 intracerebral haemorrhage 63 abnormal clotting 63 NATRECOR ® 62 severe exacerbations 62 papillary renal cell carcinoma 62 unfavorable cytogenetics 62 bone marrow suppression 62 hepatic fat 62 induce orthostatic hypotension 62 lymphopenia 62 Teriflunomide 62 triglyceride concentrations 62 vitreous floaters 62 severe renal insufficiency 62 quetiapine XR 62 gadobutrol 62 Tasigna prolongs 62 elevated serum creatinine 62 metabolic acidosis 62 favorable tolerability 62 pharmacodynamic PD 62 thromboembolic 62 cTnI 62 â ‰ ¥ 62 antibody titer 62 S/GSK# 62 serum phosphate levels 62 bezafibrate 62 left ventricular diastolic 62 Renal impairment 62 leukocyte counts 62 diarrhea nausea vomiting 62 urinary albumin 62 dapagliflozin plus 62 transaminase elevation 62 Hypocalcemia 62 pruritus itching 62 thyroid stimulating hormone 62 LAB CGRP 62 systemic corticosteroid 62 coronary stenosis 62 zonisamide SR 62 pAkt 62 elevated triglyceride levels 62 constipation nausea 62 torsade de pointes 62 apolipoprotein B 62 torsemide ER 62 systemic hypotension 62 mucosal inflammation 62 elevated prolactin 62 Microalbuminuria 62 PSA nadir 62 interstitial pneumonia 62 serum insulin 62 serum ferritin 62 blood Phe levels 62 4mg/kg 62 ULORIC 62 pericardial effusion 62 total cholesterol LDL 62 serum parathyroid hormone 62 cTnT 62 LV ejection fraction 62 lipohypertrophy 62 hepatorenal syndrome 62 elevated IOP 62 parathyroid carcinoma 62 serum LDL cholesterol 62 myeloproliferative diseases 62 ß blockers 62 HBeAg positive patients 62 thromboembolic complications 62 anaphylactoid reactions 62 N telopeptide 62 dopaminergic therapy 62 del 5q MDS 62 tumor regressions 62 cerebral ischemia 62 gastroduodenal 62 Torsades de Pointes 62 renal insufficiency 62 alkaline phosphatase 62 hypocalcemia 62 serum calcium 62 oral hypoglycemic agents 62 elevated fasting glucose 62 reduce serum phosphate 62 airway hyperresponsiveness 62 supine hypertension 62 fasting insulin 62 linaclotide treated 62 alanine transaminase 62 atypical ductal hyperplasia 62 prostate abnormalities 62 serum lipid 62 CrCl 62 Fibrillex TM 62 acitretin 62 homocysteine concentrations 62 arterial thromboembolic events 62 coinfected patients 62 β blocker 62 pamidronate 61 inhaled budesonide 61 ARCALYST ® 61 hemoglobin concentrations 61 hematological toxicities 61 alpha interferons 61 isoproterenol 61 spirometric 61 HIV RNA 61 left ventricular dysfunction 61 B7 H3 61 adrenal suppression 61 orthostatic hypotension 61 primidone 61 anemia thrombocytopenia 61 Histologic 61 Thrombotic events 61 Thalomid ® 61 serum glucose 61 EEG abnormalities 61 torcetrapib atorvastatin 61 chronic eosinophilic leukemia 61 mcg BID 61 HER2 overexpression 61 adverse cytogenetics 61 neurologic symptoms 61 included exfoliative dermatitis 61 diabetic kidney 61 liver metastasis 61 QTcF 61 Drospirenone 61 anginal pain 61 lymphocyte counts 61 bone marrow reticulin 61 ATACAND 61 mg BID dose 61 ALT elevations 61 serum lipids 61 MERLIN TIMI 61 nodal metastasis 61 abnormal glucose metabolism 61 hepatic dysfunction 61 baseline serum creatinine 61 elevated transaminases 61 myeloperoxidase 61 HoFH 61 elevated triglycerides 61 urine albumin 61 x ULN 61 swelling edema 61 adrenocortical cancer 61 retrograde ejaculation 61 COPEGUS therapy 61 NNT = 61 hyperinsulinemia 61 COPD exacerbations 61 nondiabetic patients 61 biologic DMARD 61 incidence ≥ 61 dermatologic reactions 61 ventricular tachyarrhythmia 61 scintigraphic 61 diarrhea dyspepsia 61 Tardive dyskinesia 61 NPH insulin 61 symptomatic hyponatremia 61 hypercholesterolaemia 61 plasma lipid 61 events TEAEs 61 refractory gout 61 metabolic disturbances 61 C Reactive Protein 61 BEXXAR Therapeutic Regimen 61 hyperprolactinemia 61 fatigue diarrhea nausea 61 mycophenolic acid 61 protein excretion 61 microvessel density 61 steroid dexamethasone 61 certolizumab 61 rFVIIa 61 plasma triglyceride levels 61 8mg/kg 61 albiglutide 61 triglycerides TG 61 Subgroup analysis 61 gemifloxacin 61 hepatic function 61 salmeterol HFA MDI 61 unknown etiology 61 serum lactate 61 nausea constipation 61 hypoglycemic events 61 neovasculature 61 pulmonary hypertension PH 61 serum magnesium 61 Hypersensitivity reactions 61 ARCOXIA 61 lumbar spine bone 61 anemia hemoglobin 61 thromboembolic disease 61 angina myocardial infarction 61 ecchymosis 61 squalamine 61 LDL cholesterol HDL cholesterol 61 QTc intervals 61 Thrombocytopenia 61 thrombocytopenic 61 FOLPI 61 autonomic dysfunction 61 Pharmacokinetic parameters 61 renal cysts 61 hyperalgesia 61 methylmalonic acid 61 alanine transaminase ALT 61 hypoperfusion 61 hyperkalemia 61 T1c 61 atrioventricular block 61 Dose limiting toxicities 61 abdominal distension 61 Xelox 61 TNF Tumor Necrosis Factor 61 lipid lowering agents 61 nonvertebral fractures 61 cardiac troponin 61 CCyR 61 intima media thickness 61 recurrent glioblastoma multiforme 61 hypogonadotropic hypogonadism 61 thiazide 61 postoperative morbidity 61 bullous 61 fibrin deposition 61 clevidipine 61 thyrotoxicosis 61 Subgroup analyzes 61 TNFalpha 61 baseline HbA1c 61 metastatic malignant 61 octreotide LAR 61 venlafaxine Effexor 61 c reactive protein 61 granulomatous 61 severe neutropenia 61 thyrotropin 61 Severe hypersensitivity reactions 61 efalizumab 61 atherogenic lipids 61 leukopenia 61 cytopenia 61 GI bleeds 61 glycated hemoglobin levels 61 rebleeding 61 antiphospholipid syndrome 61 malignancy HCM 61 cisplatin gemcitabine 61 azilsartan medoxomil 61 natriuretic peptides 61 Skin sterol 61 erythema redness 60 antiretroviral naive 60 TRAIL R1 60 PAOD 60 fluoxetine paroxetine 60 nimodipine 60 hypokalemia 60 macrovascular events 60 CYP #A# 60 carotid IMT 60 artery stenosis 60 elevated LDL cholesterol 60 heparin induced thrombocytopenia 60 troponin T 60 abnormal lipid 60 μg L 60 limiting toxicity 60 NSAID induced GI 60 rs# [004] 60 urothelial 60 fatigue nausea vomiting 60 plasma cortisol 60 demonstrated clinically meaningful 60 tHcy 60 DETROL LA 60 Clinically significant 60 pyrexia mucositis sepsis febrile 60 severe hepatic insufficiency 60 Paxil paroxetine 60 mycophenolate mofetil 60 acute humoral rejection 60 carcinoids 60 nadolol 60 serum triglyceride levels 60 transferrin saturation 60 neutrophil counts 60 NNRTI resistance 60 histologic 60 novel VDA molecule 60 metabolite concentrations 60 antiretroviral naïve 60 mg kg dose 60 Syndrome RLS 60 doxorubicin cyclophosphamide 60 diarrhea headache nausea 60 cerebrovascular events 60 CHD CVD 60 mL/min/#.# m 2 60 lopinavir r arm 60 erythema nodosum 60 Adverse reactions 60 PCWP 60 ibandronate 60 hepatic failure 60 periprocedural 60 complement inhibitor eculizumab 60 symptomatic VTE 60 PRADAXA #mg 60 lichen planus 60 BYSTOLIC 60 PROactive study 60 ZOLINZA 60 electrolyte abnormalities 60 mean ± SEM 60 piroxicam 60 symptomatic intracranial 60 neovascular 60 myoglobinuria rhabdomyolysis 60 plasma creatinine 60 clinically insignificant 60 abdominal adiposity 60 HBeAg negative patients 60 baseline LDH 60 plasma leptin 60 atherogenic dyslipidemia 60 hematologic adverse 60 lipid elevations 60 cardiac troponin T 60 Toxicities 60 bacteriuria 60 serum vitamin D 60 Pharmacodynamic 60 recurrent ischemia 60 ocular adverse 60 nonvertebral fracture 60 Linagliptin 60 pulmonary exacerbation 60 sonographically 60 Vaprisol 60 total cholesterol triglycerides 60 hemoptysis 60 triacylglycerol concentrations 60 plasma folate 60 carcinoembryonic antigen 60 oxycodone CR 60 serum estradiol 60 elevated uric acid 60 proliferative diabetic retinopathy 60 endometrial hyperplasia 60 discontinuations due 60 paresthesias 60 clomipramine 60 Stent thrombosis 60 maximal doses 60 hematopoietic cancers 60 TIMP 1 60 glycated hemoglobin HbA1c 60 ACTOS ® 60 choroidal neovascularization CNV 60 Ki# 60 riociguat 60 SIADH 60 chromosomal rearrangement 60 phototoxicity 60 lipid parameters 60 fractional shortening 60 CIMZIA ™ 60 Avandia Actos 60 eosinophil count 60 selective agonists 60 Cmax 60 gastrointestinal perforations 60 fasting triglycerides 60 airflow limitation 60 SPRYCEL ® 60 Serum concentrations 60 serum prostate 60 glomerular 60 squamous histology 60 CLA supplementation 60 gastrointestinal adverse reactions 60 symptomatic paroxysmal AF 60 QT interval prolongation 60 FOSRENOL ® 60 pioglitazone HCl 60 insulin detemir 60 #mg/day [002] 60 genotypic resistance 60 parkinsonian symptoms 60 TOVIAZ 60 nausea vomiting headache 60 serum albumin 60 moderate hepatic impairment 60 Proteinuria 60 NATRECOR R 60 pouchitis 60 postoperative chemotherapy 60 cardiac repolarization 60 liver histology 60 metformin accumulation 60 bilirubin elevations 60 gastrointestinal ulcers 60 Dasatinib 60 metaplasia 60 hepatic insufficiency 60 umol L 60 Certolizumab pegol 60 vasodilatory 60 apneic episodes 60 cardiovascular ischemic 60 basal bolus regimen 60 aplastic anemia AA 60 thyroid carcinoma 60 olmesartan 60 urolithiasis 60 events thrombocytopenia neutropenia 60 venous thromboembolic disease 60 Lactic acidosis 60 torsades de pointes 60 prolactin elevation 60 sonographic findings 60 renal cell carcinomas 60 isoprostane 60 ispinesib administered 60 predisposing factor 60 rosuvastatin #mg 60 metaglidasen 60 neointimal 60 ursodeoxycholic acid 60 antiangiogenic therapy 60 Hypertriglyceridemia 60 advanced adenoma 60 ara C 60 carotid plaque 60 hemorrhagic complications 60 hyperglycaemia 60 cervical lymph nodes 60 intestinal permeability 60 platelet dysfunction 60 TNF antagonist 60 interferon IFN 60 atherosclerotic vascular disease 60 systolic dysfunction 60 creatinine levels 60 quetiapine Seroquel 60 parasitemia 60 secondary hyperparathyroidism 60 Severe infusion 60 serum PTH 60 mmHg diastolic 60 thyrotropin levels 60 dyslipidemia abnormal 60 mild hepatic impairment 60 lactic acidosis 60 recurrent UTI 60 hA# 60 TREDAPTIVE 60 natriuresis 60 ACTEMRA TM 60 triiodothyronine 60 OAB symptoms 60 antimuscarinic 60 urate levels 60 creatinine clearance 60 intraoperative complications 60 hamartomas 60 occlusive disease 60 achieved CCyR 60 Retrograde ejaculation 60 factor PlGF 60 somnolence fatigue 60 cardiac conduction 60 neurocognitive deficits 60 DAS# CRP 60 prolactin levels 60 hepatic toxicity 60 mucinous 60 NAbs 60 antigen PSA levels 60 #.#mg/dL 60 gallium nitrate 60 PROCRIT ® 60 INVEGA ® 60 anemia leukopenia 60 lenalidomide dexamethasone 60 intensive statin therapy 59 cholestasis 59 verapamil 59 microglial activation 59 F FDG PET 59 platelet reactivity 59 PSA kinetics 59 angiotensin converting enzyme inhibitor 59 glycosylated hemoglobin levels 59 hepatocellular carcinomas 59 neutropaenia 59 GH deficiency 59 laboratory abnormalities 59 postprocedure 59 severe asthma exacerbations 59 polyp recurrence 59 cervicitis 59 dizziness somnolence 59 serum concentrations 59 anterior uveitis 59 reticulocytes 59 nitrotyrosine 59 hypervascular 59 CTEPH 59 definite stent thrombosis 59 Peripheral edema 59 advanced adenomas 59 GSK# [001] 59 LV dysfunction 59 leukocytosis 59 radiographic findings 59 Primary Hypercholesterolemia 59 angioedema 59 hepatic cirrhosis 59 ertapenem 59 severe renal impairment 59 virologic failure 59 hives itching 59 corticosteroid therapy 59 aleglitazar 59 perioperatively 59 glucose insulin 59 GnRH agonist 59 Elevated serum 59 CYP#D# inhibitor 59 capillary leak 59 CVD mortality 59 sulfonylurea metformin 59 Fibrates 59 thalidomide Thalomid 59 pCR 59 HES CEL 59 endothelial activation 59 sunitinib Sutent 59 Hepatic Impairment 59 plasma HCV RNA 59 pegaptanib 59 papilledema 59 lesional 59 gross hematuria 59 dizziness headache nausea 59 coagulation parameters 59 cardiac toxicity 59 parecoxib 59 febrile neutropenia 59 ischemia driven 59 gadolinium enhanced 59 vascular reactivity 59 tibolone 59 KRAS mutant tumors 59 hematologic abnormalities 59 ischemic colitis 59 atherosclerotic lesion 59 allogeneic HSCT 59 hypocalcaemia 59 O PPDS 59 invasive ductal breast cancer 59 Thromboembolic 59 nasopharyngitis 59 oxcarbazepine 59 NIHSS 59 gastrointestinal perforation 59 Eltrombopag 59 Effexor venlafaxine 59 osteosarcomas 59 efaproxiral 59 TOP2A gene 59 renal cortical 59 tumor histology 59 pulmonary toxicity 59 avosentan 59 hydroxy vitamin D 59 warfarin erythromycin 59 opioid naïve 59 chills fever headache 59 sweat chloride 59 circulating endothelial cells 59 rash urticaria 59 hematologic toxicities 59 rosuvastatin Crestor 59 MTHFD1L gene 59 eosinophilic pneumonia 59 calculi 59 diabetes dyslipidemia 59 primary hyperparathyroidism 59 peritoneal fluid 59 colorectal liver metastases 59 serum GGT 59 PSADT 59 FDG uptake 59 vasoactive 59 intracerebral hemorrhage 59 binary restenosis 59 mucosal healing 59 HbA 1c levels 59 HOMA IR 59 potassium sparing diuretics 59 neuropsychiatric adverse 59 thyroid hormone levels 59 beta blocker therapy 59 olanzapine LAI 59 histologically confirmed 59 HGPIN 59 iPTH 59 dysglycemia 59 serum uric acid sUA 59 hypercoagulable 59 NSAID induced 59 CHD mortality 59 hepatocellular 59 mitoxantrone plus 59 Secondary endpoints 59 IL 1ß 59 conventional DMARDs 59 motesanib 59 mild renal impairment 59 dysmotility 59 intima media thickness IMT 59 salmeterol fluticasone 59 ximelagatran 59 fatigue abdominal pain 59 interleukin IL -# 59 aplindore 59 aspirin clopidogrel 59 INCB# [003] 59 hematological adverse 59 pulmonary infiltrates 59 Thal Dex 59 lymphadenopathy 59 affective psychosis 59 Tarceva TM 59 pericardial effusions 59 #mg BID [001] 59 hypersensitivity allergic reactions 59 pharmacodynamic parameters 59 fatty infiltration 59 multivariate adjustment 59 fetal malformations 59 lupus anticoagulant 59 erythropoietic 59 femoral neck fracture 59 erythema edema 59 Secondary efficacy endpoints 59 gastro oesophageal reflux 59 receptor inhibitor 59 heavily pretreated 59 radiochemotherapy 59 immunoreactivity 59 glucose triglycerides 59 tipranavir r 59 intravitreal injections 59 somnolence sedation 59 tegaserod 59 vasodilatation 59 bronchial hyperresponsiveness 59 gastric adenocarcinoma 59 lipid abnormalities 59 Helicobacter pylori eradication 59 carotid stenosis 59 See CLINICAL PHARMACOLOGY 59 estimated glomerular filtration 59 vascular dysfunction 59 neutropenia febrile neutropenia 59 leukopenia pancytopenia thrombocytopenia 59 euthyroid 59 Hashimoto thyroiditis 59 VAPRISOL 59 PRADAXA 59 bronchoalveolar lavage fluid 59 TMP SMX 59 hepatic arterial 59 prednisone prednisolone plus 59 lymph node enlargement 59 Intraocular Pressure 59 intravesical therapy 59 diarrhea vomiting nausea 59 cerebrovascular accidents 59 Asymptomatic 59 Atherosclerotic 59 Aspartate 59 beta carotene supplementation 59 statin monotherapy 59 postoperative mortality 59 KCNH2 59 virologic responses 59 Non inferiority 59 aripiprazole Abilify 59 airway hyper responsiveness 59 dyslipidaemia 59 urinary excretion 59 biliary tract disease 59 Serum creatinine 59 antidepressants fluoxetine 59 sUA 59 sarcomatoid 59 XIENCE V PROMUS Stent 59 phentermine topiramate 59 μmol L 59 nephrotoxic drugs 59 NSABP C 59 medically inoperable 59 IIIa inhibitor 59 cholecystitis 59 thyroglobulin 59 mU liter 59 acarbose 59 Zemplar Capsules 59 hypometabolism 59 Hematologic toxicity 59 biochemical relapse 59 dosing frequency 59 liver enzyme 59 EpCAM expression 59 QNEXA 59 candesartan cilexetil 59 Pharmacokinetic 59 postoperative complication 59 Prostate specific antigen 59 Uncontrolled hypertension 59 Severe hypoglycemia 59 NMDA antagonists 59 pulmonary capillary wedge 59 neuropsychiatric symptoms 59 flutamide 59 mucocutaneous reactions 59 Apolipoprotein B 59 cortical atrophy 59 adrenal insufficiency 59 vitamin D inadequacy 59 endometrial carcinoma 59 MULTAQ 59 hypoglycaemic episodes 59 NIASPAN 59 unmeasured confounders 59 atazanavir ritonavir 59 nephrotoxic 59 postprandial blood glucose 59 RAPAMUNE 59 antidiabetic drug 59 MYLOTARG 59 clinically meaningful reductions 59 hyperbilirubinemia 59 Entereg R 59 CR CRu 59 Immune reconstitution syndrome 59 headache nausea fatigue 59 esophageal gastric 59 adalimumab Humira 59 plasma homocysteine 59 neurocognitive outcomes 59 ß carotene 59 divalproex sodium 59 serum bicarbonate 59 thrombotic complications 59 sitosterol 59 PHPT 59 ventricular dilatation 59 nephrolithiasis 59 non metastatic osteosarcoma 59 Adverse events 59 blood Phe 59 Orthostatic hypotension 59 locoregional recurrence 59 hyperparathyroidism 59 asthenia fatigue